Skip to main content
Nephron is fully inspected, and approved by the FDA!
Close

Kennedy to Columbia Regional Business Report: "It's a Chamber of Commerce Day!"

November 18, 2020

With promising news about a COVID-19 vaccine making headlines, Lou Kennedy had reason for optimism during Tuesday's beam-raising ceremony marking a milestone for a $215.8 million expansion at Nephron Pharmaceutical Corp.’s Saxe-Gotha Industrial Park campus.

Part of the expansion is a 110,000-square-foot vaccine production, chemotherapy and antibiotic wing that Kennedy, Nephron owner and CEO, expects to be operational around March 2021. She said Nephron is actively looking for a vaccine production partner to provide the ammunition for the pre-filled sterile syringes that make up the booming 503B Outsourcing Facility arm of the company.

“It’s a Chamber of Commerce day,” Kennedy said after signing the final beam of the 240,000-square-foot Kennedy Innovation Center’s steel skeleton on a crisp, clear morning. “This marks a milestone in 2020. This is good news. This is giving us the space to continue to grow.”